CVS’ Aetna To Meld Cancer Treatment Approvals As Insurers Cut Hurdles
CVS Health’s Aetna will bundle cancer treatments into a single clinical review as the industry works to further eliminate the controversial prior authorization process.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.forbes.com — the content belongs to Forbes.